-
Clinical rationale of sucroferric oxyhydroxide for controlling hyperphosphatemia in patients with chronic kidney disease
Stuart M Sprague, Morgan Marcuccilli & Viatcheslav Rakov
Drug Evaluation: Clinical Investigation
-
Clinical rationale of sucroferric oxyhydroxide for controlling hyperphosphatemia in patients with chronic kidney disease
Stuart M Sprague, Morgan Marcuccilli & Viatcheslav Rakov
Drug Evaluation: Clinical Investigation
-
Clinical rationale of sucroferric oxyhydroxide for controlling hyperphosphatemia in patients with chronic kidney disease
Stuart M Sprague, Morgan Marcuccilli & Viatcheslav Rakov
Drug Evaluation: Clinical Investigation
-
Clinical rationale of sucroferric oxyhydroxide for controlling hyperphosphatemia in patients with chronic kidney disease
Stuart M Sprague, Morgan Marcuccilli & Viatcheslav Rakov
Drug Evaluation: Clinical Investigation
-
Clinical rationale of sucroferric oxyhydroxide for controlling hyperphosphatemia in patients with chronic kidney disease
Stuart M Sprague, Morgan Marcuccilli & Viatcheslav Rakov
Drug Evaluation: Clinical Investigation
-
Clinical rationale of sucroferric oxyhydroxide for controlling hyperphosphatemia in patients with chronic kidney disease
Stuart M Sprague, Morgan Marcuccilli & Viatcheslav Rakov
Drug Evaluation: Clinical Investigation
-
Clinical rationale of sucroferric oxyhydroxide for controlling hyperphosphatemia in patients with chronic kidney disease
Stuart M Sprague, Morgan Marcuccilli & Viatcheslav Rakov
Drug Evaluation: Clinical Investigation
-
Clinical rationale of sucroferric oxyhydroxide for controlling hyperphosphatemia in patients with chronic kidney disease
Stuart M Sprague, Morgan Marcuccilli & Viatcheslav Rakov
Drug Evaluation: Clinical Investigation
-
Alitretinoin for the treatment of chronic hand eczema: clinical rationale
Vivian Y Shi, Raja K Sivamani & Howard Maibach
Review Article: Clinical Investigation
-
Alitretinoin for the treatment of chronic hand eczema: clinical rationale
Vivian Y Shi, Raja K Sivamani & Howard Maibach
Review Article: Clinical Investigation
-
Alitretinoin for the treatment of chronic hand eczema: clinical rationale
Vivian Y Shi, Raja K Sivamani & Howard Maibach
Review Article: Clinical Investigation
-
Alitretinoin for the treatment of chronic hand eczema: clinical rationale
Vivian Y Shi, Raja K Sivamani & Howard Maibach
Review Article: Clinical Investigation
-
Alitretinoin for the treatment of chronic hand eczema: clinical rationale
Vivian Y Shi, Raja K Sivamani & Howard Maibach
Review Article: Clinical Investigation
-
Alitretinoin for the treatment of chronic hand eczema: clinical rationale
Vivian Y Shi, Raja K Sivamani & Howard Maibach
Review Article: Clinical Investigation
-
Alitretinoin for the treatment of chronic hand eczema: clinical rationale
Vivian Y Shi, Raja K Sivamani & Howard Maibach
Review Article: Clinical Investigation
-
Alitretinoin for the treatment of chronic hand eczema: clinical rationale
Vivian Y Shi, Raja K Sivamani & Howard Maibach
Review Article: Clinical Investigation
-
Clinical trial transparency and the evaluation of new medicines
Bina Rawal and Bryan R Deane
Editorial: Clinical Investigation
-
Clinical trial transparency and the evaluation of new medicines
Bina Rawal and Bryan R Deane
Editorial: Clinical Investigation
-
Clinical trial transparency and the evaluation of new medicines
Bina Rawal and Bryan R Deane
Editorial: Clinical Investigation
-
Clinical trial transparency and the evaluation of new medicines
Bina Rawal and Bryan R Deane
Editorial: Clinical Investigation
-
Clinical trial transparency and the evaluation of new medicines
Bina Rawal and Bryan R Deane
Editorial: Clinical Investigation
-
Clinical trial transparency and the evaluation of new medicines
Bina Rawal and Bryan R Deane
Editorial: Clinical Investigation
-
Clinical trial transparency and the evaluation of new medicines
Bina Rawal and Bryan R Deane
Editorial: Clinical Investigation
-
Clinical trial transparency and the evaluation of new medicines
Bina Rawal and Bryan R Deane
Editorial: Clinical Investigation
-
Inclusion of patients with brain metastases in clinical trials
Lauren E Abrey
Editorial: Clinical Investigation
-
Inclusion of patients with brain metastases in clinical trials
Lauren E Abrey
Editorial: Clinical Investigation
-
Inclusion of patients with brain metastases in clinical trials
Lauren E Abrey
Editorial: Clinical Investigation
-
Inclusion of patients with brain metastases in clinical trials
Lauren E Abrey
Editorial: Clinical Investigation
-
Inclusion of patients with brain metastases in clinical trials
Lauren E Abrey
Editorial: Clinical Investigation
-
Inclusion of patients with brain metastases in clinical trials
Lauren E Abrey
Editorial: Clinical Investigation
-
Inclusion of patients with brain metastases in clinical trials
Lauren E Abrey
Editorial: Clinical Investigation
-
Inclusion of patients with brain metastases in clinical trials
Lauren E Abrey
Editorial: Clinical Investigation
-
Adjuvant trials for pancreatic cancer: where are we going and what is needed?
Suzanne Russo, Roger Ove, Carlo Contreras, Muhammad Wasif Saif
Review Article: Clinical Investigation
-
Adjuvant trials for pancreatic cancer: where are we going and what is needed?
Suzanne Russo, Roger Ove, Carlo Contreras, Muhammad Wasif Saif
Review Article: Clinical Investigation
-
Adjuvant trials for pancreatic cancer: where are we going and what is needed?
Suzanne Russo, Roger Ove, Carlo Contreras, Muhammad Wasif Saif
Review Article: Clinical Investigation
-
Adjuvant trials for pancreatic cancer: where are we going and what is needed?
Suzanne Russo, Roger Ove, Carlo Contreras, Muhammad Wasif Saif
Review Article: Clinical Investigation
-
Adjuvant trials for pancreatic cancer: where are we going and what is needed?
Suzanne Russo, Roger Ove, Carlo Contreras, Muhammad Wasif Saif
Review Article: Clinical Investigation
-
Adjuvant trials for pancreatic cancer: where are we going and what is needed?
Suzanne Russo, Roger Ove, Carlo Contreras, Muhammad Wasif Saif
Review Article: Clinical Investigation
-
Adjuvant trials for pancreatic cancer: where are we going and what is needed?
Suzanne Russo, Roger Ove, Carlo Contreras, Muhammad Wasif Saif
Review Article: Clinical Investigation
-
Adjuvant trials for pancreatic cancer: where are we going and what is needed?
Suzanne Russo, Roger Ove, Carlo Contreras, Muhammad Wasif Saif
Review Article: Clinical Investigation